Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Montefiori: VIMC |
| Strategy: | Combo: DNA, protein & vector vaccines |
| Study Type: | Pre-Clinical NHP |
| Species: | Rhesus macaque |
| Stage: | Assays Completed |
| Study Start Date: | 2010-09-10 |
| Study Made Public: | 2011-09-15 |
Title
MHRP’s SHIV-E ALVAC NHP Study
Description
CAVD 323 is a non-human primate challenge study comparing DNA, MVA, and protein prime/boost regimens.
Sign in to see full information about this study and to download study data.
Products
MVA-SIV-Gag-Pol MVA-HIV-Gag-Pol DNA-SIV-Gag-Pol DNA-HIV-E MVA-HIV-E oligomeric CM235 Env SHIV E Ras3C BupivacaineIntegrated data
NAb
Non-integrated data
No non-integrated data is available for this study.